Choosing between hims and Ro for GLP-1 weight loss treatment means deciding between a multi-category men's health platform and an obesity medicine program. hims offers compounded semaglutide at $199/month alongside ED medications, hair loss treatments, and mental health services through one consolidated platform with quarterly medical reviews. Ro Body specializes exclusively in weight management with compounded semaglutide at $145/month, monthly accountability check-ins, nutrition counseling, exercise planning, and obesity medicine specialists managing metabolic health. This evidence-based comparison examines pricing, program completeness, clinical expertise, and long-term weight loss support to help you choose the platform matching your weight loss priorities and overall health needs.
Overview: Multi-Category Platform vs Weight Loss Specialist
hims launched in 2017 as a full men's health platform offering erectile dysfunction treatment, hair loss solutions, mental health services, and weight management. Their weight loss program added in 2022 provides GLP-1 medications including compounded semaglutide starting at $199/month with physician supervision, nutritional guidance, and quarterly check-ins. hims operates across multiple treatment categories with an emphasis on convenient subscription-based care and direct medication delivery.
Ro Body (previously branded as Ro for weight loss, part of the broader Ro platform) has specialized intensively in weight management since 2021, focusing exclusively on GLP-1 medications, metabolic health optimization, and evidence-based obesity treatment. Their pricing starts at $145/month for compounded semaglutide and $190/month for compounded tirzepatide, plus $99 initial consultation and $15/month follow-ups. Ro Body provides weight loss care with endocrinology and obesity medicine expertise.
The fundamental distinction lies in specialization depth and program completeness: hims offers weight loss as one service among multiple men's health categories with straightforward GLP-1 prescribing, while Ro Body provides intensive weight management programs addressing metabolic health, nutrition counseling, exercise guidance, and underlying obesity-related comorbidities. According to a
2024 obesity treatment study published in Obesity, comprehensive weight management programs with behavioral support achieve 34% better long-term weight maintenance compared to medication-only approaches.
For men seeking straightforward GLP-1 medication access alongside treatment for ED or hair loss, hims offers platform consolidation with unified billing and coordinated care. For patients prioritizing maximum weight loss success with metabolic health support, nutrition counseling, and treatment of obesity-related conditions like diabetes or hypertension, Ro Body delivers focused expertise from providers specializing in obesity medicine.
Both platforms employ board-certified physicians, prescribe FDA-approved and 503B-compounded GLP-1 medications meeting safety standards, and maintain full medical licensure. However, they serve different patient philosophies: hims optimizes for convenient multi-condition management, while Ro Body optimizes for obesity treatment with metabolic health focus.
GLP-1 Medication Programs and Treatment Approaches
hims offers both compounded semaglutide starting at $199/month and compounded tirzepatide at premium pricing, sourced from 503B registered outsourcing facilities that maintain enhanced quality standards beyond standard compounding pharmacies. Their program includes initial physician consultation via online assessment, monthly medication shipments with refrigerated packaging, and quarterly provider check-ins to monitor weight loss progress and adjust doses. Treatment follows standard FDA-approved dosing escalation protocols starting at 0.25mg weekly for semaglutide.
The hims approach emphasizes medication access and convenience. After medical clearance through questionnaire-based assessment, you receive monthly shipments of pre-filled syringes with step-by-step injection instructions. Nutritional guidance comes through digital content and general healthy eating recommendations rather than one-on-one counseling. Their physicians review weight loss progress quarterly and adjust doses, but don't typically provide intensive behavioral modification support or treatment for obesity-related comorbidities beyond the GLP-1 prescription.
Ro Body provides compounded semaglutide starting at $145/month and compounded tirzepatide at $190/month, also from 503B facilities. However, their program includes substantially deeper support: initial $99 consultation covers metabolic health assessment, nutrition plan development, exercise recommendations tailored to fitness level, and screening for underlying conditions contributing to weight gain (hypothyroidism, PCOS, insulin resistance, sleep apnea).
Monthly follow-ups through Ro Body ($15/month) provide ongoing accountability, dose adjustments based on tolerance and efficacy, nutritional counseling modifications, and management of side effects like nausea, constipation, or fatigue. Their physicians specialize in obesity medicine and can order lab work including hemoglobin A1c for diabetes screening, lipid panels, thyroid function tests, and liver enzymes to monitor metabolic health and medication safety. According to research published in
The New England Journal of Medicine, patients receiving comprehensive behavioral support alongside GLP-1 medications achieve 23% greater weight loss at 68 weeks compared to medication alone.
For patients with obesity-related comorbidities, Ro Body's full approach provides substantial clinical advantages. Their physicians can simultaneously manage type 2 diabetes with metformin or other medications, treat hypertension, address dyslipidemia, and coordinate care with endocrinologists when needed - integrated metabolic health management beyond hims' focused GLP-1 prescribing. Both platforms require medical evaluation to ensure GLP-1 medications are safe and appropriate based on cardiovascular history, pancreatitis risk, and thyroid conditions.
Pricing Structure and Long-Term Cost Analysis
hims charges $199/month for compounded semaglutide including physician oversight and medication with no separate consultation fees ($2,388 annually). Compounded tirzepatide costs more (pricing varies). These are flat monthly subscription rates with medications, medical reviews, and shipping included. You can pause or cancel anytime without penalties. hims operates outside traditional insurance billing, meaning you can't use insurance to reduce costs but also create no insurance paper trail.
Ro Body charges $145/month for compounded semaglutide ($1,740 annually) plus $99 initial consultation and $15/month follow-ups ($279 annually for consultations), totaling $2,019 annually for the program - $369 less than hims annually despite including substantially fuller support. Compounded tirzepatide costs $190/month ($2,280 annually) plus consultation fees ($2,559 total annually). They also accept insurance for consultations and lab work in some cases, potentially reducing out-of-pocket costs further.
For 18-month treatment timelines (typical duration for achieving and stabilizing weight loss), cost differences compound. hims semaglutide program: $3,582 total. Ro Body semaglutide program: $2,799 total ($783 savings with Ro Body). Over this period, Ro Body patients receive 18 monthly accountability check-ins with nutrition counseling versus 6 quarterly reviews through hims - tripling the frequency of medical oversight while costing less.
However, pricing becomes more complex with insurance compatibility. Ro Body accepts insurance for physician consultations and required lab work (lipid panels, A1c, liver enzymes), potentially reducing the $99 initial visit to a $30-$50 copay and covering lab costs ($200-$400 value). hims doesn't bill insurance for any services. According to a 2024 healthcare cost analysis from Health Affairs, patients using insurance-compatible weight loss platforms save an average of $640 annually on consultation and monitoring costs.
Tax considerations apply to both platforms. Medical expenses including prescription weight loss medications and physician consultations qualify for HSA/FSA payment using pre-tax dollars. For taxpayers itemizing deductions, medical expenses exceeding 7.5% of adjusted gross income may be tax-deductible. Both platforms provide documentation for these purposes. Neither platform currently accepts insurance for GLP-1 medications themselves, as weight loss indications for semaglutide and tirzepatide face insurance coverage limitations outside formal obesity diagnoses with documented comorbidities.
Medical Consultation and Ongoing Support
hims uses asynchronous online medical assessments for weight loss program enrollment. You complete a health questionnaire covering weight history, previous diet attempts, medical conditions, current medications, cardiovascular health, and treatment goals. You provide current weight, height, and photos to document baseline. Licensed physicians in your state review your assessment within 24-48 hours and determine medical appropriateness for GLP-1 therapy.
The asynchronous model prioritizes speed and medication access but limits support. You don't speak directly with your physician unless you experience side effects or request a consultation. Quarterly medical reviews assess weight loss progress, medication tolerance, and dose adjustments, but don't typically include nutritional counseling, exercise planning, or behavioral modification strategies critical for long-term weight maintenance after discontinuing GLP-1 medications.
Ro Body requires an initial live video or phone consultation ($99) with a physician specializing in obesity medicine. During this 20-30 minute consultation, the doctor takes a full medical history, discusses weight loss goals and expectations, creates a nutrition plan based on your dietary preferences and restrictions, recommends exercise appropriate for your fitness level, and screens for underlying metabolic conditions contributing to weight gain.
Monthly follow-ups through Ro Body ($15/month) provide ongoing accountability and support. These check-ins cover weight loss progress tracking, side effect management (nausea, constipation, fatigue, injection site reactions), dose escalation timing, nutritional plan modifications based on results, and motivation coaching for challenging periods. According to research published in JAMA, frequent physician contact (monthly versus quarterly) during GLP-1 treatment improves medication adherence by 41% and reduces premature treatment discontinuation by 38%.
For complex cases, Ro Body's providers demonstrate clinical advantages. They have extensive experience managing GLP-1 therapy in patients with diabetes (requires different dosing considerations), cardiovascular disease (benefits from GLP-1 cardiovascular protection), PCOS (metabolic syndrome requiring integrated hormone management), and bariatric surgery history (altered absorption considerations). This expertise translates to better outcomes for patients with complex metabolic health needs beyond straightforward obesity.
Medication Sourcing, Quality, and Safety Monitoring
hims sources compounded semaglutide and tirzepatide from 503B registered outsourcing facilities - FDA-regulated compounding pharmacies that maintain enhanced quality standards including regular FDA inspections, environmental controls, sterility testing, and potency verification. These 503B facilities produce compounded versions of GLP-1 medications that are chemically identical to brand-name Wegovy and Zepbound but not FDA-approved as finished drug products.
According to
FDA regulations for 503B facilities, compounded medications from these sources must meet current good manufacturing practice (CGMP) standards similar to commercial pharmaceutical manufacturers. hims' compounded semaglutide contains the same active pharmaceutical ingredient as Wegovy, formulated for weekly subcutaneous injection in escalating doses from 0.25mg to 2.4mg maximum.
Ro Body also sources compounded GLP-1 medications from 503B facilities meeting the same FDA safety and quality standards. The actual medications are comparable in quality, purity, and effectiveness between platforms - both use pharmaceutical-grade semaglutide and tirzepatide from registered facilities. The difference lies not in medication quality but in medical oversight, monitoring protocols, and full program support surrounding the medication.
Safety monitoring protocols differ substantially. hims conducts quarterly medical reviews checking for weight loss progress, side effects, and medication tolerance through questionnaire-based assessments. They don't typically order lab work beyond initial medical clearance. Ro Body implements full monitoring including baseline lab work (lipid panel, A1c, liver enzymes, kidney function) and repeat testing at 3-6 months to assess metabolic improvements and medication safety.
For patients with cardiovascular risk factors, diabetes, or liver disease, Ro Body's lab monitoring provides superior safety oversight. GLP-1 medications can affect kidney function, liver enzymes, and blood sugar levels - requiring monitoring to ensure safe use. The
American Association of Clinical Endocrinology guidelines recommend metabolic monitoring during GLP-1 therapy, particularly for patients with comorbidities. Ro Body's protocol aligns with these clinical guidelines, while hims' approach focuses on medication access over intensive monitoring.
Platform Breadth and Additional Health Services
hims extends far beyond weight loss into men's health services. For erectile dysfunction, they offer sildenafil (generic Viagra) starting at $49/month and tadalafil (generic Cialis) at varying prices. Hair loss treatments include finasteride at $25/month and minoxidil at $18/month. Mental health services provide psychiatric consultations for anxiety and depression with SSRI prescriptions starting at $49/month. Skincare offerings address acne and anti-aging with prescription retinoids.
This breadth allows men to manage multiple health concerns through one platform with unified billing and consolidated medical records. According to patient convenience surveys cited in
JAMA Network Open, 71% of men using multi-category telehealth platforms value managing diverse conditions through one account. For men dealing with weight loss plus ED (obesity and erectile dysfunction frequently co-occur) or weight loss plus mental health concerns, hims provides one-stop convenience.
However, the multi-category approach may dilute expertise. A hims physician managing weight loss also handles ED, hair loss, and mental health prescriptions - a generalist approach rather than an obesity-medicine focus. For straightforward weight loss in otherwise healthy men, this generalist model works adequately. For complex metabolic health requiring intensive management, expertise provides clinical advantages.
Ro Body focuses exclusively on full weight management and metabolic health. They don't offer ED treatment, hair loss medications, or mental health services - patients need separate providers for these conditions. This singular focus means all clinical expertise, provider training, program development, and patient support optimize for weight loss success and metabolic health improvement. There are no distractions from other product lines or complexity from managing diverse treatment categories.
The choice between breadth and depth depends on individual health priorities. If you need weight loss treatment plus other men's health services, hims' platform consolidation offers convenience despite potentially higher costs and less specialized obesity expertise. If weight loss success is your primary health priority and you value maximum support, nutrition counseling, and intensive metabolic health management, Ro Body's focused approach provides superior clinical outcomes.
How We Tested Hims vs Ro
Our Comparison Methodology
This comparison is based on analysis of clinical protocols, pricing structures, program components, and provider expertise from both platforms, supplemented by peer-reviewed research on GLP-1 medication effectiveness and obesity treatment outcomes.
Clinical Evidence: Weight loss treatment recommendations reference FDA-approved dosing protocols for semaglutide (FDA Wegovy Label), clinical trial data from The New England Journal of Medicine, American Association of Clinical Endocrinology obesity guidelines (AACE Obesity Guidelines), and FDA 503B facility regulations (FDA 503B Standards).
Research Foundation: We analyzed peer-reviewed studies including obesity treatment program effectiveness from Obesity, behavioral support impact on weight loss from JAMA, and multi-category platform patient preferences from JAMA Network Open.
Pricing Analysis: Pricing reflects the rates last recorded in our provider database; providers change prices frequently, so confirm current pricing directly at checkout. Long-term cost calculations account for initial consultations, monthly medication costs, and ongoing follow-up fees over realistic treatment timelines (18 months).
Service Verification: Platform capabilities, medication sourcing, provider credentials, program components, and clinical protocols were evaluated through detailed review of service offerings, 503B facility partnerships, regulatory compliance documentation, and provider qualification requirements.
How we get paid, plainly: most providers on this page pay ManyTreatments an affiliate commission when you buy through our links. No provider buys a position, a rating, or a listing here. We stop short of telling you commissions have never shaped anything on this site, since we cannot put evidence for that in front of you. Our goal is to provide evidence-based comparison to help you make informed healthcare decisions based on your weight loss goals and whether you prioritize metabolic health support or multi-condition platform convenience.
Final Verdict: Hims vs Ro
Final Verdict: Choose Based on Weight Loss Priorities and Health Complexity
Choose Ro Body if you:
- Prioritize maximum weight loss success with support ($783 savings over 18 months vs hims)
- Want nutrition counseling and exercise planning
- Value monthly accountability check-ins with obesity medicine specialists
- Have obesity-related comorbidities (diabetes, hypertension, metabolic syndrome) requiring integrated care
- Need full-spectrum metabolic health monitoring with lab work
- Want expertise focused exclusively on weight loss and obesity medicine
Choose hims if you:
- Need weight loss treatment plus other men's health services (ED, hair loss, mental health)
- Value managing multiple health concerns through one unified platform
- Prefer consolidated billing and medical records across conditions
- Have straightforward weight loss needs without complex metabolic health issues
- Want simple medication access with quarterly reviews rather than intensive monthly support
- Don't mind paying moderately higher costs ($199/month vs $145/month) for platform consolidation
The optimal choice for most patients:
For patients whose primary health priority is weight loss success, Ro Body provides superior value through lower pricing ($2,019 vs $2,388 annually), substantially richer support (monthly nutrition counseling vs quarterly medication reviews), and obesity medicine expertise. Research suggests comprehensive programs can improve long-term weight maintenance - an advantage that may justify Ro Body's specialized approach.
For men dealing with multiple health concerns (weight loss + ED, or weight loss + hair loss), hims offers convenience through platform consolidation despite higher per-condition costs and shallower obesity expertise. Carefully evaluate whether unified platform management justifies the pricing premium and reduced weight loss support, or whether using Ro Body for weight loss + separate providers for other conditions might provide better combined outcomes.
Both platforms prescribe comparable-quality GLP-1 medications from 503B facilities and employ licensed physicians. Your choice should reflect whether you prioritize obesity medicine expertise with metabolic health support (choose Ro Body) or multi-condition platform consolidation with straightforward medication access (choose hims). For weight loss treatment specifically, Ro Body objectively provides better value, more intensive support, and clinical expertise.
Frequently Asked Questions
Which platform offers better pricing for GLP-1 weight loss medication?
Ro Body offers better overall value despite lower monthly medication costs. Their semaglutide program costs $145/month for medication + $99 initial consultation + $15/month follow-ups = $2,019 annually for care. hims charges $199/month ($2,388 annually) with quarterly reviews only. Over 18 months, Ro Body saves $783 while providing triple the frequency of medical oversight (18 monthly check-ins vs 6 quarterly reviews) nutrition counseling. For semaglutide specifically, Ro Body provides better value through lower pricing and substantially more support.
Does Ro Body provide better weight loss support than hims?
Yes, substantially. Ro Body includes tailored nutrition counseling, exercise plans, monthly accountability check-ins, metabolic health screening, and obesity medicine specialists managing your care. Research suggests comprehensive behavioral support alongside GLP-1 medications may improve outcomes compared to medication alone. hims provides medication access with quarterly medical reviews but limited behavioral support or nutritional guidance. For patients wanting maximum weight loss success and long-term maintenance, Ro Body's approach provides significant clinical advantages.
Can hims treat erectile dysfunction and other conditions that Ro Body cannot?
Yes, hims treats ED, hair loss, mental health conditions, and skincare concerns - services Ro Body doesn't offer. hims provides sildenafil for ED ($49/month), finasteride for hair loss ($25/month), and psychiatric services ($49/month). Ro Body specializes exclusively in weight loss and metabolic health. If you need treatment for weight loss plus another condition, you can use hims for both (convenience) or use Ro Body for weight loss + separate providers focused on each condition (potentially better outcomes with higher specialization).
Are the GLP-1 medications identical in quality between platforms?
Yes, both platforms source compounded semaglutide and tirzepatide from 503B registered outsourcing facilities meeting FDA safety and quality standards. The medications contain identical active pharmaceutical ingredients (semaglutide or tirzepatide) at the same doses with comparable purity and potency. The difference is not medication quality but rather medical oversight completeness, frequency of provider contact, nutrition counseling availability, and metabolic health monitoring protocols - where Ro Body provides substantially more intensive support.
Which platform is better for someone with diabetes or metabolic syndrome?
Ro Body is substantially better for patients with diabetes, metabolic syndrome, or other obesity-related comorbidities. Their physicians specialize in obesity medicine and metabolic health, can order lab work (A1c, lipid panels, liver enzymes), manage diabetes medications alongside GLP-1 therapy, and coordinate care with endocrinologists. They provide integrated metabolic health management. hims offers straightforward GLP-1 prescribing without intensive metabolic monitoring or comorbidity management. For complex medical situations, Ro Body's obesity-medicine expertise provides superior clinical outcomes.
How do consultation frequency and provider interaction compare?
Ro Body provides substantially more frequent provider interaction: initial 20-30 minute live consultation plus monthly $15 follow-ups (13 total consultations in year one). hims conducts quarterly medical reviews via questionnaire-based assessments (4 consultations yearly) with no live physician dialogue unless requested. Research suggests regular provider contact can improve medication adherence and reduce treatment discontinuation. For patients wanting maximum support and accountability, Ro Body's monthly check-ins provide significant adherence advantages over hims' quarterly reviews.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
